dehydroevodiamine has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CF; Chou, CJ; Liao, JF; Wang, HH | 1 |
1 other study(ies) available for dehydroevodiamine and Alzheimer Disease
| Article | Year |
|---|---|
Dehydroevodiamine attenuates beta-amyloid peptide-induced amnesia in mice.
Topics: Alkaloids; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Avoidance Learning; Cholinesterase Inhibitors; Male; Mice; Mice, Inbred ICR; Muscarinic Antagonists; Peptide Fragments; Physostigmine; Scopolamine | 2001 |